Sandoz Australia is threatening to withdraw patches from public subsidy list if government does not agree to price hike
Pharmaceutical company Sandoz Australia is in a standoff with the federal government over the pricing of hormone patches relied on by thousands of women. There is a risk that if an agreement is not reached the drug will only be available under private prescription, which would significantly increase the price.
Estradot, Estalis Sequi and Estalis Continuous patches are subsidised by the government under the Pharmaceutical Benefits Scheme (PBS), and are used by women for the relief of symptoms of menopause.
Related: Patients frantic over mysterious global shortage of HRT medications and contraceptive pills